Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CRON

CRON - Cronos Group Inc Stock Price, Fair Value and News

$2.66-0.05 (-1.85%)
Market Closed

56/100

CRON

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

56/100

CRON

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.8

Target 3M

$2.79

Target 6M

$2.79

CRON Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CRON Price Action

Last 7 days

1.9%

Last 90 days

9.0%

Trailing 12 Months

40.7%

CRON RSI Chart

CRON Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CRON Valuation

Market Cap

1.0B

Price/Earnings (Trailing)

26.08

Price/Sales (Trailing)

5.78

EV/EBITDA

5.4

Price/Free Cashflow

-189.66

CRON Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.8

Target 3M

$2.79

Target 6M

$2.79

CRON Fundamentals

CRON Revenue

Revenue (TTM)

176.2M

Rev. Growth (Yr)

4.79%

Rev. Growth (Qtr)

10.34%

CRON Earnings

Earnings (TTM)

39.1M

Earnings Growth (Yr)

210.91%

Earnings Growth (Qtr)

167.45%

CRON Profitability

EBT Margin

23.39%

Return on Equity

3.61%

Return on Assets

3.31%

Free Cashflow Yield

-0.53%

CRON Investor Care

Shares Dilution (1Y)

0.16%

Diluted EPS (TTM)

0.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025168.4M173.9M176.2M0
2024129.1M142.0M154.6M161.8M
2023107.6M106.3M114.2M120.3M
202294.4M102.6M104.1M110.5M
202160.7M67.0M73.3M79.6M
2020961.1M768.7M271.6M54.4M
20190001.2B
20180000
20170000
20160000
Get all data in R, Python etc through our Historical Stock Data APIs

About Cronos Group Inc

CRON
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
 CEO
 WEBSITEthecronosgroup.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES447

Cronos Group Inc Frequently Asked Questions

CRON is the stock ticker symbol of Cronos Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Cronos Group Inc is 1.02 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CRON's fair value in chart for subscribers.

The fair value guage provides a quick view whether CRON is over valued or under valued. Whether Cronos Group Inc is cheap or expensive depends on the assumptions which impact Cronos Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CRON.

As of Wed Jan 28 2026, CRON's PE ratio (Price to Earnings) is 26.08 and Price to Sales (PS) ratio is 5.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CRON PE ratio will change depending on the future growth rate expectations of investors.